Pharmacologic Inhibition of Tpl2 Blocks Inflammatory Responses in Primary Human Monocytes, Synoviocytes, and Blood-Reference-Cited by-同舟云学术

Pharmacologic Inhibition of Tpl2 Blocks Inflammatory Responses in Primary Human Monocytes, Synoviocytes, and Blood

Published:2007-11 Issue:46 Volume:282 Page:33295-33304
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hall J. Perry,Kurdi Yahya,Hsu Sang,Cuozzo John,Liu Julie,Telliez Jean-Baptiste,Seidl Katherine J.,Winkler Aaron,Hu Yonghan,Green Neal,Askew G. Roger,Tam Steve,Clark James D.,Lin Lih-Ling

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference33 articles.

1. Tpl2/Cot Signals Activate ERK, JNK, and NF-κB in a Cell-type and Stimulus-specific Manner

2. TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway

3. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals

4. Tpl2 transduces CD40 and TNF signals that activate ERK and regulates IgE induction by CD40

5. Genetic Dissection of the Cellular Pathways and Signaling Mechanisms in Modeled Tumor Necrosis Factor–induced Crohn's-like Inflammatory Bowel Disease

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building polarization into protein-inhibitor binding dynamics in rational drug design for rheumatoid arthritis;Journal of Biomolecular Structure and Dynamics;2023-06-28

2. Tumor progression locus 2 (TPL2): A Cot-plicated progression from inflammation to chronic liver disease;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-04

3. The Tpl2‐MEK pathway plays a critical role in spheroid‐cultured endometriotic stromal cells;American Journal of Reproductive Immunology;2023-02-22

4. Inhibition of the TPL2-MKK1/2-ERK1/2 pathway has cytostatic effect on B-Cell Lymphoma;2022-06-16

5. New Druggable Targets for Rheumatoid Arthritis Based on Insights From Synovial Biology;Frontiers in Immunology;2022-02-21